Cargando…
Experimental, Clinical and Morphological Analysis of H-Ras Oncoproteins for Locally Advanced Breast Cancer
BACKGROUND: Activated forms of Ras are enhanced in both breast cancer as well as the cell lines with EGFR and HER2 expression. Therefore, H-Ras could be activated in breast tumours in the absence of direct mutational activation of Ras itself and could contribute to 20-50% of the cases. Expression in...
Autores principales: | Zhumakayeva, A. M., Rakhimov, K. D., Omarova, I. M., Arystan, L. I., Adekenov, S. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953936/ https://www.ncbi.nlm.nih.gov/pubmed/31949508 http://dx.doi.org/10.3889/oamjms.2019.708 |
Ejemplares similares
-
Neoadjuvant Therapy with Drug Arglabin for Breast Cancer with Expression of H-Ras Oncoproteins
por: Adekenov, Sergazy, et al.
Publicado: (2020) -
Polymorphic variants of H-RAS protooncogene and their possible role in bladder cancer etiology
por: Traczyk, Magdalena, et al.
Publicado: (2012) -
The oncoprotein H-Ras(V12 )increases mitochondrial metabolism
por: Telang, Sucheta, et al.
Publicado: (2007) -
Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma
por: Slemmons, Katherine K., et al.
Publicado: (2015) -
A bacterial toxin that cleaves Ras oncoprotein
por: Biancucci, Marco, et al.
Publicado: (2015)